Hospira, Dr. Reddy’s Infringe Eli Lilly Cancer Treatment Patent (1) – Bloomberg Law

Hospira, Dr. Reddy’s Infringe Eli Lilly Cancer Treatment Patent (1)  Bloomberg Law

Hospira Inc. and Dr. Reddy’s Laboratories Ltd. infringed an Eli Lilly & Co. patent covering its cancer drug Alimta, the Federal Circuit said Aug. 9.